| Molecular classification of gastric cancer: Towards a pathway-driven targeted therapy I Riquelme, K Saavedra, JA Espinoza, H Weber, P García, B Nervi, ... Oncotarget 6 (28), 24750, 2015 | 160 | 2015 |
| The inflammatory inception of gallbladder cancer JA Espinoza, C Bizama, P García, C Ferreccio, M Javle, JF Miquel, ... Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1865 (2), 245-254, 2016 | 141 | 2016 |
| miR-101-2, miR-125b-2 and miR-451a act as potential tumor suppressors in gastric cancer through regulation of the PI3K/AKT/mTOR pathway I Riquelme, O Tapia, P Leal, A Sandoval, MG Varga, P Letelier, ... Cellular oncology 39, 23-33, 2016 | 141 | 2016 |
| The gene expression status of the PI3K/AKT/mTOR pathway in gastric cancer tissues and cell lines I Riquelme, O Tapia, JA Espinoza, P Leal, K Buchegger, A Sandoval, ... Pathology & Oncology Research 22, 797-805, 2016 | 113 | 2016 |
| Integrity of mitochondrial membrane potential reflects human sperm quality JA Espinoza, MA Schulz, R Sánchez, JV Villegas Andrologia 41 (1), 51-54, 2009 | 111 | 2009 |
| Targeting specific molecular pathways holds promise for advanced gallbladder cancer therapy C Bizama, P García, JA Espinoza, H Weber, P Leal, B Nervi, JC Roa Cancer Treatment Reviews 41 (3), 222-234, 2015 | 77 | 2015 |
| Cytokine profiling of tumor interstitial fluid of the breast and its relationship with lymphocyte infiltration and clinicopathological characteristics JA Espinoza, S Jabeen, R Batra, E Papaleo, V Haakensen, ... Oncoimmunology 5 (12), e1248015, 2016 | 65 | 2016 |
| The exon-junction complex helicase eIF4A3 controls cell fate via coordinated regulation of ribosome biogenesis and translational output DC Kanellis, JA Espinoza, A Zisi, E Sakkas, J Bartkova, AM Katsori, ... Science advances 7 (32), eabf7561, 2021 | 54 | 2021 |
| The antimalarial drug amodiaquine stabilizes p53 through ribosome biogenesis stress, independently of its autophagy-inhibitory activity JA Espinoza, A Zisi, DC Kanellis, J Carreras-Puigvert, M Henriksson, ... Cell Death & Differentiation 27 (2), 773-789, 2020 | 51 | 2020 |
| Noninvasive profiling of serum cytokines in breast cancer patients and clinicopathological characteristics S Jabeen, JA Espinoza, LA Torland, M Zucknick, S Kumar, ... Oncoimmunology 8 (2), e1537691, 2019 | 44 | 2019 |
| Mitochondrial membrane potential disruption pattern in human sperm JA Espinoza, U Paasch, JV Villegas Human reproduction 24 (9), 2079-2085, 2009 | 44 | 2009 |
| The low‐abundance transcriptome reveals novel biomarkers, specific intracellular pathways and targetable genes associated with advanced gastric cancer C Bizama, F Benavente, E Salvatierra, A Gutiérrez‐Moraga, JA Espinoza, ... International journal of cancer 134 (4), 755-764, 2014 | 41 | 2014 |
| Reversal of gastrointestinal carcinoma-induced immunosuppression and induction of antitumoural immunity by a combination of cyclophosphamide and gene transfer of IL-12 M Malvicini, M Ingolotti, F Piccioni, M Garcia, J Bayo, C Atorrasagasti, ... Molecular Oncology 5 (3), 242-255, 2011 | 36 | 2011 |
| Small molecule inhibitor screening identifified HSP90 inhibitor 17-AAG as potential therapeutic agent for gallbladder cancer H Weber, JR Valbuena, MA Barbhuiya, S Stein, H Kunkel, P García, ... Oncotarget 8 (16), 26169, 2017 | 31 | 2017 |
| FABP7 and HMGCS2 are novel protein markers for apocrine differentiation categorizing apocrine carcinoma of the breast P Gromov, JA Espinoza, ML Talman, N Honma, N Kroman, VT Wielenga, ... PLoS One 9 (11), e112024, 2014 | 28 | 2014 |
| Hippo-YAP1 is a prognosis marker and potentially targetable pathway in advanced gallbladder cancer P García, L Rosa, S Vargas, H Weber, JA Espinoza, F Suárez, ... Cancers 12 (4), 778, 2020 | 27 | 2020 |
| Low expression of equilibrative nucleoside transporter 1 is associated with poor prognosis in chemotherapy‐naïve pT2 gallbladder adenocarcinoma patients JA Espinoza, P García, C Bizama, JL Leal, I Riquelme, H Weber, ... Histopathology 68 (5), 722-728, 2016 | 19 | 2016 |
| Mucin 5B, carbonic anhydrase 9 and claudin 18 are potential theranostic markers of gallbladder carcinoma JA Espinoza, I Riquelme, EA Sagredo, L Rosa, P García, C Bizama, ... Histopathology 74 (4), 597-607, 2019 | 18 | 2019 |
| Reduced expression of PROX1 transitions glioblastoma cells into a mesenchymal gene expression subtype KM Goudarzi, JA Espinoza, M Guo, J Bartek, M Nistér, MS Lindström, ... Cancer research 78 (20), 5901-5916, 2018 | 18 | 2018 |
| Rapamycin and WYE-354 suppress human gallbladder cancer xenografts in mice H Weber, P Leal, S Stein, H Kunkel, P García, C Bizama, JA Espinoza, ... Oncotarget 6 (31), 31877, 2015 | 18 | 2015 |
Carolina BizamaDepartment of Pathology. Pontificia Universidad Católica de Chileuc.cl üzerinde doğrulanmış e-posta adresine sahip
